Covetrus, Inc.
CVET · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/29/2018 | |
|---|---|---|---|---|
| Revenue | $4,575,000 | $4,339,000 | $3,976,000 | $3,777,994 |
| % Growth | 5.4% | 9.1% | 5.2% | – |
| Cost of Goods Sold | $3,717,000 | $3,541,000 | $3,227,000 | $3,093,882 |
| Gross Profit | $858,000 | $798,000 | $749,000 | $684,112 |
| % Margin | 18.8% | 18.4% | 18.8% | 18.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $867,000 | $808,000 | $538,469 |
| SG&A Expenses | $881,000 | $867,000 | $808,000 | $538,469 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $881,000 | $867,000 | $808,000 | $538,469 |
| Operating Income | -$22,000 | -$69,000 | -$997,000 | $137,098 |
| % Margin | -0.5% | -1.6% | -25.1% | 3.6% |
| Other Income/Exp. Net | -$32,000 | $43,000 | -$32,000 | $6,079 |
| Pre-Tax Income | -$54,000 | -$26,000 | -$1,029,000 | $143,177 |
| Tax Expense | $32,000 | -$7,000 | -$7,000 | $37,028 |
| Net Income | -$86,000 | -$19,000 | -$1,019,000 | $100,861 |
| % Margin | -1.9% | -0.4% | -25.6% | 2.7% |
| EPS | -0.63 | -0.16 | -9.52 | 0.91 |
| % Growth | -293.7% | 98.3% | -1,146.2% | – |
| EPS Diluted | -0.63 | -0.16 | -9.52 | 0.91 |
| Weighted Avg Shares Out | 137,000 | 118,000 | 107,000 | 111,193 |
| Weighted Avg Shares Out Dil | 137,000 | 118,000 | 107,000 | 111,193 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,000 | $7,000 | $0 |
| Interest Expense | $32,000 | $47,000 | $56,000 | $0 |
| Depreciation & Amortization | $200,000 | $190,000 | $176,000 | $64,100 |
| EBITDA | $179,000 | $213,000 | -$794,000 | $201,989 |
| % Margin | 3.9% | 4.9% | -20% | 5.3% |